HP Pavilion Plus 14 – Design, Feel, Display, Keyboard, Configuration, Performance – Unboxing and Evaluation

Processor: Intel Core Ultra 5 125H Graphics Chip: Intel Arc Memory: 16GB LPDDR5X Storage: 1TB PCIe NVMe M.2 SSD Screen Size and Specifications: 14-inch 2.8K resolution, 120Hz refresh rate, OLED (supports IMAX Enhanced audio certification) Ports: USB-A x 2 (5Gbps x 1 + 10Gbps x 1), USB-C x 2 (40Gbps supporting Thunderbolt 4 x 1…

Read More

Microsoft Releases Chatbot for US Intelligence Agencies

Microsoft has unveiled a generative AI model based on GPT-4, specifically developed for US intelligence agencies, which operates without internet connection. This marks Microsoft’s first deployment of a large language model in a secure environment. It allows intelligence services to analyze top-secret information without the risk of internet leaks and securely communicate with a chatbot…

Read More

Japanese Gamers Outraged Over Announcement of Assassin’s Creed: Shadows

The cinematic trailer for the new Assassin’s Creed turned out to be impressive, but it evoked mixed feelings among many players. The series is finally reaching the most desired setting among fans – feudal Japan. However, the realization of the game seemed very controversial to most users. Players are debating Assassin’s Creed: Shadows for various…

Read More

In the Top500 ranking, the new supercomputer Aurora placed only second

The Aurora supercomputer, powered by Intel processors, was unable to surpass the Frontier supercomputer, powered by AMD chips, in the latest Top500 ranking of the world’s fastest supercomputers, placing second. Nevertheless, Aurora topped the ranking in the HPL-MxP test, designed to evaluate performance in artificial intelligence, achieving 10.6 AI exaflops and becoming the fastest AI…

Read More

The first combined vaccine against influenza and COVID-19 has been developed

Scientists at the pharmaceutical company Moderna have developed the first mRNA vaccine targeting both influenza and coronavirus. This combined vaccine successfully completed Phase 3 clinical trials and is awaiting approval from the US regulator FDA. According to Nature, the combined vaccine has shown higher efficacy compared to monovalent vaccines targeting only one virus. mRNA technology…

Read More